SONN

Sonnet BioTherapeutics Holdings, Inc. (SONN) | Rumor.io

Sonnet BioTherapeutics Holdings

SONN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)68%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about SONN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% +0

Dec 3

Sonnet BioTherapeutics Holdings, Inc. ($SONN) shareholders approved a merger to form a new company, $HYPE DAT, with a potential $1B raise.
The merger has closed, and Sonnet BioTherapeutics will become a wholly owned subsidiary of Hyperliquid Strategies Inc., which will operate as a digital asset treasury reserve company.
The merger has led to significant market impact, with $SONN experiencing a 59.35% decline in value to $1.26.

Generated by AI

Sentiment

Of the messages about SONN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	92.67% +1.92
Bearish	—	—	—	7.33% -1.92

Bullish· Jul 3

$SONN is showing significant bullish momentum, with a massive volume spike and a breakout from a bullish flag pattern.
The stock's RSI is fueling its upward move, breaking through resistance levels and confirming yesterday's breakout energy.
$SONN has the potential for a second leg of growth, with a possible continuation setup to $4.40-$4.80, if the $3.60 base holds.

Bearish· Aug 24

$SONN has a history of gapping up 14 times in the last 5 years, with all of them closing below the open price.
Shorting $SONN can be challenging due to low-quality executions, high borrow prices, and difficulties in getting filled on the backside.
$SONN has significant resistance around $2.75-$2.80, making it difficult to break through and potentially leading to further selling pressure.

Generated by AI

Topics

Of the messages about SONN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	36.1%
Announcements	—	—	—	18.47%
Controversies	—	—	—	0%
Earnings	—	—	—	5%
Macro	—	—	—	31.11%
Technical Analysis	—	—	—	9.32%

Nov 6

Sonnet BioTherapeutics Holdings, Inc. ($SONN) has announced the issuance of a U.S. patent covering a variant IL-18 incorporated into two novel immunotherapeutic drug candidates.
The company has priced a $5.0 million underwritten public offering at $4.50 per share, selling 1.11 million shares and warrants for an additional 2.22 million shares.
Sonnet BioTherapeutics has seen a 120% price increase following the announcement of the patent issuance.

Generated by AI

Community

Of the messages about SONN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	40.87%
Newcomers	—	—	—	59.13%

Regulars· Dec 9

The price of $SONN has broken its downtrend and may lead to a short squeeze to $5+.
A price of $6.30++ may be the next daily expansion for big moves, and the author has stops under $3.75 to keep it green.
Sonnet BioTherapeutics has announced topline safety data following the successful completion of its Phase 1 SB101 trial, with a 46% pre-market price spike.

Newcomers· Dec 2

Newcomers are focusing on the post-merger fair value of Sonnet BioTherapeutics Holdings, with some estimating it to be around $2.45 per share.
There is a debate among newcomers about the true net asset value (NAV) per share of Sonnet BioTherapeutics, with one estimate suggesting it to be around $1.23.
The company's stockholders have approved a business combination with Hyperliquid Strategies and Rorschach I, leading to a decline in the stock's price.

Generated by AI

Also Discussed

Investors talking about SONN also mention

#	Name	Attention
1	Dogwood Therapeutics Inc.VIRI	0%0
2	ADMA Biologics, Inc.ADMA	0%+0
3	China Liberal Education Holdings LimitedCLEU	0%new
4	Better Therapeutics, Inc.BTTX	0%new
5	YS - YS Biopharma Co., Ltd.	——
6	NVOS - Novo Integrated Sciences, Inc.	——
7	Cosmos Health Inc.COSM	0.02%+0.01
8	ZVSA - ZyVersa Therapeutics, Inc.	——
9	GT Biopharma Inc.GTBP	0%0
10	Mega Matrix Inc.MPU	0%0